Design and Synthesis of 1,2-Deoxy-pyranose Derivatives of Spliceostatin A toward Prostate Cancer Treatment
- 1 May 2020
- journal article
- letter
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 11 (6) , 1310-1315
Abstract
We designed and synthesized a novel 1,2-deoxy-pyranose and terminal epoxide methyl substituted derivatives of spliceostatin A using Julia–Kocienski olefination as a key step. With respect to the biological activity, the 1,2-deoxy-pyranose analogue of spliceostatin A suppressed AR-V7 expression at the nano level (IC50 = 3.3 nM). In addition, the in vivo toxicity test showed that the 1,2-deoxy-pyranose analogue was able to avoid severe toxicity compared to spliceostatin A.Keywords
Funding Information
- Japan Agency for Medical Research and Development (JP19am0101084)
- Japan Society for the Promotion of Science (JP 18H04260, JP A16H010260, JP A262880510, JP T15K149760, JP T15KT00630)
- Shorai Foundation for Science and Technology
This publication has 43 references indexed in Scilit:
- Design and synthesis of a phenyl C-glycoside derivative of Spliceostatin A and its biological evaluation toward prostate cancer treatmentTetrahedron Letters, 2019
- SF3B2-Mediated RNA Splicing Drives Human Prostate Cancer ProgressionCancer Research, 2019
- Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable RORγ Inverse Agonist for Treatment of Castration-Resistant Prostate CancerJournal of Medicinal Chemistry, 2019
- Developing new targeting strategy for androgen receptor variants in castration resistant prostate cancerInternational Journal of Cancer, 2017
- Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targetingProstate Cancer and Prostatic Diseases, 2016
- ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancerNature Medicine, 2016
- Enzalutamide in Metastatic Prostate Cancer before ChemotherapyNew England Journal of Medicine, 2014
- Decoding the androgen receptor splice variants2013
- Abiraterone in Metastatic Prostate Cancer without Previous ChemotherapyNew England Journal of Medicine, 2013
- Increased Survival with Enzalutamide in Prostate Cancer after ChemotherapyNew England Journal of Medicine, 2012